Sodium valproate is associated with cortical thinning of disease-specific areas in juvenile myoclonic epilepsy.

Valproate was associated with JME-specific and dose-dependent thinning of the cortical motor regions. This suggests that valproate is a key modulator of cortical morphology in JME, an effect that may underlie its high efficacy in this syndrome.